These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2825483)
41. The metabolism of leukotriene B4 by peripheral blood polymorphonuclear leukocytes in psoriasis. Maurice PD; Camp RD; Allen BR Prostaglandins; 1987 Jun; 33(6):807-18. PubMed ID: 2823314 [TBL] [Abstract][Full Text] [Related]
42. Rickettsial effects on leukotriene and prostaglandin secretion by mouse polymorphonuclear leukocytes. Walker TS; Hoover CS Infect Immun; 1991 Jan; 59(1):351-6. PubMed ID: 1846125 [TBL] [Abstract][Full Text] [Related]
43. Comparison of the generation in vitro of chemotactically active LTB4 and its omega-metabolites by human neutrophils and lymphocytes/monocytes. Rosenbach T; Czarnetzki BM Clin Exp Immunol; 1987 Jul; 69(1):221-8. PubMed ID: 2820638 [TBL] [Abstract][Full Text] [Related]
45. Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils. Schröder JM J Invest Dermatol; 1986 Nov; 87(5):624-9. PubMed ID: 3021863 [TBL] [Abstract][Full Text] [Related]
46. Effects of a 5-lipoxygenase inhibitor, AA861, on lipoxygenase metabolism and superoxide anion generation by human polymorphonuclear leukocytes--potentiation of superoxide anion generation by LTB4. Tanaka K; Abe M; Shigematsu N Int Arch Allergy Immunol; 1992; 98(4):361-9. PubMed ID: 1330136 [TBL] [Abstract][Full Text] [Related]
47. Inhibitory effect of loratadine on leukotriene B4 production by neutrophils either alone or during interaction with human airway epithelial cells. Amsellem C; Czarlewski W; Lagarde M; Pachéco Y Pulm Pharmacol Ther; 1998; 11(4):245-52. PubMed ID: 10101740 [TBL] [Abstract][Full Text] [Related]
48. Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model. Cluzel M; Undem BJ; Chilton FH J Immunol; 1989 Dec; 143(11):3659-65. PubMed ID: 2555414 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate. Sperling RI; Coblyn JS; Larkin JK; Benincaso AI; Austen KF; Weinblatt ME Arthritis Rheum; 1990 Aug; 33(8):1149-55. PubMed ID: 2167685 [TBL] [Abstract][Full Text] [Related]
50. Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate. Sperling RI; Benincaso AI; Anderson RJ; Coblyn JS; Austen KF; Weinblatt ME Arthritis Rheum; 1992 Apr; 35(4):376-84. PubMed ID: 1314609 [TBL] [Abstract][Full Text] [Related]
51. Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4. Goldman DW; Gifford LA; Young RN; Marotti T; Cheung MK; Goetzl EJ J Immunol; 1991 Apr; 146(8):2671-7. PubMed ID: 1849936 [TBL] [Abstract][Full Text] [Related]
52. Impaired leukotriene B4 release by neonatal polymorphonuclear leukocytes. Viggiano D; Romano G; Caniglia M; Santoro P; Palumbo A; Ciccimarra F Pediatr Res; 1994 Jul; 36(1 Pt 1):60-3. PubMed ID: 7936838 [TBL] [Abstract][Full Text] [Related]
53. Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response. Goldman DW; Goetzl EJ J Exp Med; 1984 Apr; 159(4):1027-41. PubMed ID: 6323613 [TBL] [Abstract][Full Text] [Related]
54. Metabolism of leukotriene B4 via reduction into dihydro-leukotriene B4 in human monocytes, alveolar macrophages, and U-937 cells. Schönfeld W; Kasimir S; Knöller J; Jablonski K; König W J Leukoc Biol; 1991 Sep; 50(3):303-12. PubMed ID: 1649885 [TBL] [Abstract][Full Text] [Related]
55. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2. Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363 [TBL] [Abstract][Full Text] [Related]
56. Binding of leukotriene B4 and its analogs to human polymorphonuclear leukocyte membrane receptors. Bomalaski JS; Mong S Prostaglandins; 1987 Jun; 33(6):855-67. PubMed ID: 2823316 [TBL] [Abstract][Full Text] [Related]
57. Phospholipase A2 activation in human neutrophils requires influx of extracellular Ca2+ and leukotriene B4. Reddy S; Bose R; Rao GH; Murthy M Am J Physiol; 1995 Jan; 268(1 Pt 1):C138-46. PubMed ID: 7840141 [TBL] [Abstract][Full Text] [Related]
58. Identification and functional characterization of leukotriene B4 20-hydroxylase of human polymorphonuclear leukocytes. Soberman RJ; Harper TW; Murphy RC; Austen KF Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2292-5. PubMed ID: 2986111 [TBL] [Abstract][Full Text] [Related]
59. Leukotriene B₄ Metabolism and p70S6 Kinase 1 Inhibitors: PF-4708671 but Not LY2584702 Inhibits CYP4F3A and the ω-Oxidation of Leukotriene B₄ In Vitro and In Cellulo. Archambault AS; Turcotte C; Martin C; Lefebvre JS; Provost V; Laviolette M; Flamand N PLoS One; 2017; 12(1):e0169804. PubMed ID: 28068410 [TBL] [Abstract][Full Text] [Related]
60. NaCN inhibits the stereospecific depletion of LTB4 by guinea pig polymorphonuclear leukocytes. Pickett WC; Douglas MB Prostaglandins; 1986 Mar; 31(3):385-94. PubMed ID: 3012651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]